ASCL2 activators are specialized compounds that enhance the activity of the protein Achaete-Scute Complex-Like 2 (ASCL2), a transcription factor that plays a pivotal role in the regulation of gene expression during embryonic development and in adult stem cells. ASCL2 is known to be essential for the determination of cell fate and the maintenance of stem cell pluripotency.
Activators of ASCL2 can exert their effects through direct or indirect interactions. Direct activators might bind to ASCL2 and induce a conformational change that enhances its affinity for DNA or its ability to recruit co-activators, thereby increasing its transcriptional activity. Such activators could also stabilize the protein, prolonging its half-life and resulting in sustained gene expression of its target genes.Indirect activators could influence the expression and function of ASCL2 through various pathways. For instance, they might upregulate the transcription of the ASCL2 gene, leading to increased synthesis of the protein. Alternatively, they could inhibit the degradation pathways responsible for ASCL2 turnover, thereby increasing the cellular levels of the protein. They might also affect the post-translational modifications of ASCL2, such as phosphorylation or acetylation, which can have profound effects on its stability, localization, and interaction with other proteins involved in the transcriptional machinery.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a histone deacetylase (HDAC) inhibitor that enhances histone acetylation, thereby potentially influencing ASCL2 by promoting transcriptional activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is another HDAC inhibitor, which could potentially influence ASCL2 by enhancing histone acetylation and promoting transcriptional processes. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Mocetinostat is an HDAC inhibitor, which can potentially influence ASCL2 by modulating histone acetylation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 is a class I HDAC inhibitor, potentially influencing ASCL2 by enhancing histone acetylation and promoting transcriptional processes. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
RGFP966 is an HDAC3-specific inhibitor, which can potentially influence ASCL2 by modulating histone acetylation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid is a broad-spectrum HDAC inhibitor, which can potentially influence ASCL2 by promoting histone acetylation and transcriptional activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that can potentially influence ASCL2 by modulating transcriptional regulation. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor, which can potentially modulate ASCL2 by altering transcriptional regulation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a specific histone acetyltransferase inhibitor, potentially impacting ASCL2 by influencing histone acetylation. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $136.00 $492.00 | 13 | |
Garcinol is a histone acetyltransferase inhibitor, potentially influencing ASCL2 through modulation of histone acetylation. | ||||||